Heron Therapeutics (HRTX) Set to Announce Earnings on Tuesday

Heron Therapeutics (NASDAQ:HRTX) will be posting its quarterly earnings results before the market opens on Tuesday, November 12th. Analysts expect Heron Therapeutics to post earnings of ($0.03) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Heron Therapeutics Trading Down 1.1 %

Shares of HRTX stock opened at $1.75 on Monday. The firm has a fifty day moving average price of $1.87 and a 200 day moving average price of $2.55. The company has a market cap of $265.42 million, a P/E ratio of -5.47 and a beta of 1.81. Heron Therapeutics has a 12 month low of $0.50 and a 12 month high of $3.93.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC restated a “buy” rating and issued a $5.00 price objective on shares of Heron Therapeutics in a research note on Wednesday, September 25th.

About Heron Therapeutics

Heron Therapeutics, Inc, a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.